Topotekan — разлика између измена
Садржај обрисан Садржај додат
м .. |
м Bot: Converting bare references, using ref names to avoid duplicates, see FAQ |
||
Ред 40:
== Indikacije (Odobrena upotreba) ==
* [[Rak jajnika]] (maj [[1996]]).<ref>http://www.fda.gov/bbs/topics/NEWS/NEW00537.html</ref>
* [[Rak materice]] (jun [[2006]]).<ref>[http://www.cancer.gov/cancertopics/druginfo/fda-topotecan-hydrochloride FDA Approval for Topotecan Hydrochloride - National Cancer Institute<!-- Bot generated title -->]</ref> <ref>http://www.fda.gov/CDER/Offices/OODP/whatsnew/topotecan.htm FDA</ref>
* [[Rak malih ćelija pluća]] (SCLC) (oktobar [[2007]]).<ref>http://onctalk.com/2007/12/18/oral-topotecan-fda-approved/</ref> <ref>http://www.drugs.com/newdrugs/gsk-receives-approval-hycamtin-topotecan-capsules-relapsed-small-cell-lung-cancer-671.html Press release</ref>
| |||